← Evidence map

ArticleReumatologia clinica2021

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.

Olga Sanchez-Pernaute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2020
2021
2022
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32354685